Product Distribution Expansion: Middle East/India

Embargoed: 0700hrs, 6 September 2010

Akers Biosciences, Inc.

("ABI" or the "Company")

ABI Expands Product Distribution to the Middle East and India

Akers Biosciences, Inc (AIM:AKR), a leading designer and manufacturer of rapid diagnostic screening and testing products, is pleased to announce the addition of Al Tadawi Medical Equip TR LLC ("Al Tadawi") as a distributor of the Company's In Vitro diagnostic devices in the Middle East and India. Initially, Al Tadawi will focus on the marketing of ABI's flagship product, the PIFA Heparin/PF4 Rapid Assay, as well as the new PIFA Chlamydia Rapid Assay and the Tri-Cholesterol "Check" test. They will also distribute ABI's first-in-class, Breath Ketone "Check" test, used for diabetic management, following its launch later this year.

Al Tadawi, a medical distribution company based in Sharjah, United Arab Emirates, specialises in the distribution of generic pharmaceuticals and medical diagnostic consumables and rapid tests. Their sales and marketing efforts will be concentrated within the GCC Countries (Kuwait, Bahrain, Saudi Arabia, Qatar, United Arab Emirates and Oman), along with Iraq, Egypt and India.

Thomas A. Nicolette, Chief Executive of ABI, commented,

"We are pleased to be expanding our distribution into the Middle East and India for the first time with Al Tadawi's assistance. Just looking at their presence within Saudi Arabia, the GCC's largest healthcare market, and India, a country that boasts a consistent 23% annual growth in the medical devices market, makes this opportunity quite attractive."

Peter Felix, Chief Executive of Al Tadawi, said,

"ABI's product portfolio will offer our customers cost-saving, rapid testing solutions for medical conditions that have traditionally required the use of invasive, often expensive, diagnostic platforms. We are impressed by ABI's accurate rapid tests and turn-key training programs that can be quickly implemented into our local markets."

Enquiries:

Thomas A. Nicolette

President and CEO

Tel. +1 856 848 8698

Ben Simons

M: Communications

Tel. +44 (0)20 7920 2340

Emma Earl

Daniel Stewart

Tel. +44 (0)20 7776 6550

About Akers Biosciences, Inc.

Akers Biosciences develops, manufactures, and supplies rapid, point of care screening and testing products designed to bring healthcare information both rapidly and directly to the consumer or healthcare provider. The Company has advanced the science of diagnostics while responding to major shifts in healthcare through the development of several proprietary platform technologies. The company's state-of-the-art rapid diagnostic assays can be performed virtually anywhere in minutes when time is of the essence. ABI has aligned with major healthcare companies and high volume medical products distributorsto maximize product offerings, and to be a major worldwide competitor in diagnostics. Additional information on the Company and its products can be found at www.akersbiosciences.com.